Careers

Norton Rose Fulbright expands pharma and biotech disputes team
13 February 2026   The firm recruits two Cooley partners with expertise in Hatch-Waxman, BPCIA, trade secrets, and competitor versus competitor patent litigation.

More News

30 January 2026   Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences and transatlantic services.
29 January 2026   Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as demand for specialist patent services rises.
29 January 2026   New York-based firm makes its second key acquisition in weeks, as the firm pursues growth by broadening its litigation capabilities.
26 January 2026   The new recruit has a “stellar track record” of representing big tech in trade secret and patent litigation, and joins the firm’s newly opened San Francisco office.
22 January 2026   Orrick, Herrington & Sutcliffe adds senior litigators with experience in patent, trade secret, copyright, trademark, and commercial disputes across life sciences and technology.
16 January 2026   The team, known for pharmaceutical and biotechnology patent litigation—including Hatch-Waxman and BPCIA disputes—as well as trade secret and licensing matters, joins a rival US firm.
14 January 2026   A high-profile departure from the USPTO sees a senior appellate expert move into private practice as demand increases in the firm's life sciences IP practice.
More news